Biotech News
Leuven – 21 september 2026 – 22h00 CET Gereglementeerde informatie 1 Materialise rapporteert over de voortgang van haar op 30 oktober 2025 aangekondigde aandeleninkoopprogramma. 21 september 2026 – Materialise NV (Euronext: MTLS) (Nasdaq: MTLS)
Additive-Manufacturing Technology Materialise is a global 3D-printing company providing software, production services and medical applications. Its technology supports the design and manufacture of complex parts from digital models. Medical Solutions The medical segment develops patient-specific surgical planning tools, anatomical...
